 |
Environmental and Health Consequences of Clandestine Methamphetamine Laboratories |
Provided in coordination with the US Department of the Interior Bureau of Indian Affairs and the American College of Medical Toxicology. The Agency for Toxic Substances & Disease Registry provided prior assistance in the development of aspects of this course.
August 6, 2015, 9am-4pm
Department of Interior Federal Building
2021 4th Ave. N., Medicine Wheel Room (3rd Floor)
Billings, MT
Course Description:
This course offers a unique opportunity to learn about the clinical health effects of methamphetamine use and abuse, the hazards of synthesis, health effects of methamphetamines, and clean up and remediation of clandestine laboratories. Children's health and exposure considerations will also be presented.
Faculty:
Kurt C. Kleinschmidt, MD, FACMT, Professor of Emergency Medicine, Division Chief and Program Director of Toxicology, UT Southwestern Medical Center, Dallas, TX
Jennifer A. Lowry, MD, FACMT, Associate Professor of Pediatrics, UMKC School of Medicine. Section Chief, Toxicology, Children’s Mercy Hospital, Kansas City, MO
Evan S. Schwarz, MD, FACEP, Assistant Professor of Emergency Medicine, Medical Toxicology Fellowship Director, Washington University School of Medicine, St. Louis, MO
The ACMT faculty members are board certified and fellowship trained physician medical toxicologists. They have extensive experience directly caring for patients suffering from the ill effects of chemical agents and poisons.
Learning Objectives:
- Describe the state of methamphetamine use and clandestine meth laboratories in the US.
- Identify the clinical effects of meth and describe the management of acute and chronic toxicity.
- Describe the law enforcement perspective on methamphetamine in the community.
- Describe the chemical hazards of methamphetamine synthesis.
- Identify personal and environmental protection equipment to be used by first responders.
- Identify the modalities available to treat victims of the clandestine meth lab exposure.
- Identify the occupational monitoring requirements for responders.
- Identify the special features to be considered for the evaluation of children found at the scene.
| Agenda | |
| 8:30-9:00am | Registration |
| 9:00-9:20am |
Opening Remarks and Welcome
Tony Larvie, Special Agent, Office of Justice Services, Bureau of Indian Affairs
Kurt C. Kleinschmidt, MD, FACMT, American College of Medical Toxicology
|
| 9:20-10:05am |
History and Epidemiology of Exposure to Meth Contamination in Homes and Clandestine Labs
Evan S. Schwarz, MD, FACEP Download Slides (large file, may require several minutes to open)
|
| 10:05-10:20am | Break |
| 10:20-11:05am |
Medical Effects & Consequences
Jennifer A. Lowry, MD, FACMT |
| 11:05-11:50am |
Pediatric Considerations: The Drug Endangered Children
Jennifer A. Lowry, MD, FACMT
|
| 11:50am-1:00pm | Lunch Break |
| 1:00-1:30pm |
What is in a Meth Lab?
Kurt C. Kleinschmidt, MD, FACMT
|
| 1:30-2:00pm |
Hazards, Personal Protective Equipment (PPE), and Monitoring of Personnel
Evan S. Schwarz, MD, FACEP
|
| 2:00-2:15pm |
Break
|
| 2:15-2:45pm |
Contamination in the Homes, Testing, and Costs
Kurt C. Kleinschmidt, MD, FACMT
|
| 2:45-3:30pm |
Tabletop Exercise and Open Discussion
Faculty |
| 3:30-4:00pm | Evaluation and Conclusion |
Other information:
Government issued ID required for entry, for federal employee please utilize PIV card.